13(top 1%)
papers
250(top 1%)
citations
8(top 1%)
h-index
11(top 1%)
g-index
15
all documents
275
doc citations
170
citing journals

Top Articles

#TitleJournalYearCitations
1Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoidsNature Communications201688
2Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cellsNature Communications201859
3The assessment of depression in people with multiple sclerosis: a systematic review of psychometric validation studiesBMC Psychiatry201632
4Aurora B prevents premature removal of spindle assembly checkpoint proteins from the kinetochore: A key role for Aurora B in mitosisOncotarget201827
5Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacyBritish Journal of Cancer201723
6RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitosesBritish Journal of Cancer201714
7A novel approach to increasing community capacity for weight management a volunteer-delivered programme (ActWELL) initiated within breast screening clinics: a randomised controlled trialInternational Journal of Behavioral Nutrition and Physical Activity202111
8Behavioural text message reminders to improve participation in cervical screening: a randomised controlled trialLancet, The20178
9Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind AllianceBreast Cancer Research and Treatment20235
10Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”Trials20214
11Supporting women with breast cancer during pregnancyBritish Journal of Midwifery20202
12Abstract S6-01:BRCA1methylation status, silencing and treatment effect in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012)20172
13London Cancer Alliance: Development of a metastatic breast cancer service model and service specificationEuropean Journal of Surgical Oncology20160